Paloma Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-840
| Closed | -$407K | – | 152 |
|
2025
Q1 | $407K | Buy |
+840
| New | +$407K | 0.05% | 86 |
|
2024
Q3 | – | Sell |
-2,700
| Closed | -$1.27M | – | 1228 |
|
2024
Q2 | $1.27M | Buy |
+2,700
| New | +$1.27M | 0.04% | 206 |
|
2023
Q4 | – | Sell |
-623
| Closed | -$217K | – | 421 |
|
2023
Q3 | $217K | Sell |
623
-3,224
| -84% | -$1.12M | 0.01% | 149 |
|
2023
Q2 | $1.35M | Buy |
+3,847
| New | +$1.35M | 0.05% | 70 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 514 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 716 |
|
2022
Q2 | – | Sell |
-944
| Closed | -$246K | – | 1305 |
|
2022
Q1 | $246K | Buy |
+944
| New | +$246K | 0.01% | 956 |
|
2021
Q4 | – | Sell |
-52,912
| Closed | -$9.6M | – | 1736 |
|
2021
Q3 | $9.6M | Buy |
52,912
+15,217
| +40% | +$2.76M | 0.24% | 39 |
|
2021
Q2 | $7.6M | Buy |
37,695
+30,237
| +405% | +$6.1M | 0.14% | 79 |
|
2021
Q1 | $1.6M | Sell |
7,458
-4,572
| -38% | -$983K | 0.03% | 371 |
|
2020
Q4 | $2.84M | Buy |
12,030
+9,833
| +448% | +$2.32M | 0.07% | 188 |
|
2020
Q3 | $598K | Buy |
+2,197
| New | +$598K | 0.02% | 913 |
|
2020
Q2 | – | Sell |
-2,400
| Closed | -$571K | – | 2030 |
|
2020
Q1 | $571K | Sell |
2,400
-2,450
| -51% | -$583K | 0.03% | 385 |
|
2019
Q4 | $1.06M | Buy |
4,850
+2,599
| +115% | +$569K | 0.02% | 729 |
|
2019
Q3 | $381K | Buy |
+2,251
| New | +$381K | 0.01% | 1082 |
|
2019
Q2 | – | Sell |
-8,127
| Closed | -$1.49M | – | 1811 |
|
2019
Q1 | $1.49M | Buy |
+8,127
| New | +$1.49M | 0.04% | 376 |
|
2018
Q4 | – | Sell |
-1,305
| Closed | -$252K | – | 1410 |
|
2018
Q3 | $252K | Sell |
1,305
-4,785
| -79% | -$924K | ﹤0.01% | 1015 |
|
2018
Q2 | $1.04M | Buy |
6,090
+62
| +1% | +$10.5K | 0.02% | 497 |
|
2018
Q1 | $982K | Buy |
6,028
+1,010
| +20% | +$165K | 0.02% | 603 |
|
2017
Q4 | $752K | Sell |
5,018
-6,105
| -55% | -$915K | 0.01% | 639 |
|
2017
Q3 | $1.69M | Buy |
11,123
+7,800
| +235% | +$1.19M | 0.02% | 412 |
|
2017
Q2 | $428K | Sell |
3,323
-12,888
| -80% | -$1.66M | 0.01% | 1163 |
|
2017
Q1 | $1.77M | Sell |
16,211
-15,622
| -49% | -$1.71M | 0.02% | 508 |
|
2016
Q4 | $2.35M | Buy |
31,833
+21,179
| +199% | +$1.56M | 0.02% | 344 |
|
2016
Q3 | $929K | Sell |
10,654
-3,178
| -23% | -$277K | 0.01% | 670 |
|
2016
Q2 | $1.19M | Buy |
13,832
+3,675
| +36% | +$316K | 0.01% | 699 |
|
2016
Q1 | $807K | Buy |
10,157
+6,413
| +171% | +$510K | 0.01% | 697 |
|
2015
Q4 | $471K | Sell |
3,744
-17,766
| -83% | -$2.23M | 0.01% | 763 |
|
2015
Q3 | $2.24M | Buy |
21,510
+15,435
| +254% | +$1.61M | 0.05% | 180 |
|
2015
Q2 | $750K | Sell |
6,075
-75,794
| -93% | -$9.36M | 0.01% | 708 |
|
2015
Q1 | $9.66M | Sell |
81,869
-4,526
| -5% | -$534K | 0.27% | 36 |
|
2014
Q4 | $10.3M | Buy |
86,395
+62,859
| +267% | +$7.47M | 0.44% | 25 |
|
2014
Q3 | $2.64M | Sell |
23,536
-3,513
| -13% | -$395K | 0.12% | 147 |
|
2014
Q2 | $2.56M | Buy |
27,049
+18,849
| +230% | +$1.79M | 0.11% | 155 |
|
2014
Q1 | $580K | Buy |
8,200
+3,570
| +77% | +$253K | 0.04% | 310 |
|
2013
Q4 | $344K | Sell |
4,630
-3,370
| -42% | -$250K | 0.02% | 721 |
|
2013
Q3 | $607K | Sell |
8,000
-4,591
| -36% | -$348K | 0.02% | 444 |
|
2013
Q2 | $1.01M | Buy |
+12,591
| New | +$1.01M | 0.06% | 246 |
|